COVID-19 Impact on Global Viral Vector Development Service Market Size, Status and Forecast 2020-2026

September 2020 | 98 pages | ID: C3B715E7D10CEN
QYResearch

Abstracts

This report focuses on the global Viral Vector Development Service status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Viral Vector Development Service development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• UJIFILM Diosynth Biotechnologies
• Sanofi
• Spark Therapeutics
• UniQure
• MassBiologics
• FinVector
• Brammer Bio
• Cell and Gene Therapy Catapult
• Cobra Biologics

Market segment by Type, the product can be split into

• Retroviral Vectors
• Lentiviral Vectors
• Adenoviral Vectors
• Adeno-associated Viral Vectors
• Others Viral Vectors

Market segment by Application, split into

• Pharmaceutical Manufacturers
• Biotechnology Companies
• Research Institutes

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Viral Vector Development Service status, future forecast, growth opportunity, key market and key players.
• To present the Viral Vector Development Service development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Viral Vector Development Service are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Viral Vector Development Service Revenue
1.4 Market Analysis by Type
  1.4.1 Global Viral Vector Development Service Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Retroviral Vectors
  1.4.3 Lentiviral Vectors
  1.4.4 Adenoviral Vectors
  1.4.5 Adeno-associated Viral Vectors
  1.4.6 Others Viral Vectors
1.5 Market by Application
  1.5.1 Global Viral Vector Development Service Market Share by Application: 2020 VS 2026
  1.5.2 Pharmaceutical Manufacturers
  1.5.3 Biotechnology Companies
  1.5.4 Research Institutes
1.6 Coronavirus Disease 2019 (Covid-19): Viral Vector Development Service Industry Impact
  1.6.1 How the Covid-19 is Affecting the Viral Vector Development Service Industry
    1.6.1.1 Viral Vector Development Service Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Viral Vector Development Service Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Viral Vector Development Service Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Viral Vector Development Service Market Perspective (2015-2026)
2.2 Viral Vector Development Service Growth Trends by Regions
  2.2.1 Viral Vector Development Service Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Viral Vector Development Service Historic Market Share by Regions (2015-2020)
  2.2.3 Viral Vector Development Service Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Viral Vector Development Service Market Growth Strategy
  2.3.6 Primary Interviews with Key Viral Vector Development Service Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Viral Vector Development Service Players by Market Size
  3.1.1 Global Top Viral Vector Development Service Players by Revenue (2015-2020)
  3.1.2 Global Viral Vector Development Service Revenue Market Share by Players (2015-2020)
  3.1.3 Global Viral Vector Development Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Viral Vector Development Service Market Concentration Ratio
  3.2.1 Global Viral Vector Development Service Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Viral Vector Development Service Revenue in 2019
3.3 Viral Vector Development Service Key Players Head office and Area Served
3.4 Key Players Viral Vector Development Service Product Solution and Service
3.5 Date of Enter into Viral Vector Development Service Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Viral Vector Development Service Historic Market Size by Type (2015-2020)
4.2 Global Viral Vector Development Service Forecasted Market Size by Type (2021-2026)

5 VIRAL VECTOR DEVELOPMENT SERVICE BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Viral Vector Development Service Market Size by Application (2015-2020)
5.2 Global Viral Vector Development Service Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Viral Vector Development Service Market Size (2015-2020)
6.2 Viral Vector Development Service Key Players in North America (2019-2020)
6.3 North America Viral Vector Development Service Market Size by Type (2015-2020)
6.4 North America Viral Vector Development Service Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Viral Vector Development Service Market Size (2015-2020)
7.2 Viral Vector Development Service Key Players in Europe (2019-2020)
7.3 Europe Viral Vector Development Service Market Size by Type (2015-2020)
7.4 Europe Viral Vector Development Service Market Size by Application (2015-2020)

8 CHINA

8.1 China Viral Vector Development Service Market Size (2015-2020)
8.2 Viral Vector Development Service Key Players in China (2019-2020)
8.3 China Viral Vector Development Service Market Size by Type (2015-2020)
8.4 China Viral Vector Development Service Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Viral Vector Development Service Market Size (2015-2020)
9.2 Viral Vector Development Service Key Players in Japan (2019-2020)
9.3 Japan Viral Vector Development Service Market Size by Type (2015-2020)
9.4 Japan Viral Vector Development Service Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Viral Vector Development Service Market Size (2015-2020)
10.2 Viral Vector Development Service Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Viral Vector Development Service Market Size by Type (2015-2020)
10.4 Southeast Asia Viral Vector Development Service Market Size by Application (2015-2020)

11 INDIA

11.1 India Viral Vector Development Service Market Size (2015-2020)
11.2 Viral Vector Development Service Key Players in India (2019-2020)
11.3 India Viral Vector Development Service Market Size by Type (2015-2020)
11.4 India Viral Vector Development Service Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Viral Vector Development Service Market Size (2015-2020)
12.2 Viral Vector Development Service Key Players in Central & South America (2019-2020)
12.3 Central & South America Viral Vector Development Service Market Size by Type (2015-2020)
12.4 Central & South America Viral Vector Development Service Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 UJIFILM Diosynth Biotechnologies
  13.1.1 UJIFILM Diosynth Biotechnologies Company Details
  13.1.2 UJIFILM Diosynth Biotechnologies Business Overview and Its Total Revenue
  13.1.3 UJIFILM Diosynth Biotechnologies Viral Vector Development Service Introduction
  13.1.4 UJIFILM Diosynth Biotechnologies Revenue in Viral Vector Development Service Business (2015-2020))
  13.1.5 UJIFILM Diosynth Biotechnologies Recent Development
13.2 Sanofi
  13.2.1 Sanofi Company Details
  13.2.2 Sanofi Business Overview and Its Total Revenue
  13.2.3 Sanofi Viral Vector Development Service Introduction
  13.2.4 Sanofi Revenue in Viral Vector Development Service Business (2015-2020)
  13.2.5 Sanofi Recent Development
13.3 Spark Therapeutics
  13.3.1 Spark Therapeutics Company Details
  13.3.2 Spark Therapeutics Business Overview and Its Total Revenue
  13.3.3 Spark Therapeutics Viral Vector Development Service Introduction
  13.3.4 Spark Therapeutics Revenue in Viral Vector Development Service Business (2015-2020)
  13.3.5 Spark Therapeutics Recent Development
13.4 UniQure
  13.4.1 UniQure Company Details
  13.4.2 UniQure Business Overview and Its Total Revenue
  13.4.3 UniQure Viral Vector Development Service Introduction
  13.4.4 UniQure Revenue in Viral Vector Development Service Business (2015-2020)
  13.4.5 UniQure Recent Development
13.5 MassBiologics
  13.5.1 MassBiologics Company Details
  13.5.2 MassBiologics Business Overview and Its Total Revenue
  13.5.3 MassBiologics Viral Vector Development Service Introduction
  13.5.4 MassBiologics Revenue in Viral Vector Development Service Business (2015-2020)
  13.5.5 MassBiologics Recent Development
13.6 FinVector
  13.6.1 FinVector Company Details
  13.6.2 FinVector Business Overview and Its Total Revenue
  13.6.3 FinVector Viral Vector Development Service Introduction
  13.6.4 FinVector Revenue in Viral Vector Development Service Business (2015-2020)
  13.6.5 FinVector Recent Development
13.7 Brammer Bio
  13.7.1 Brammer Bio Company Details
  13.7.2 Brammer Bio Business Overview and Its Total Revenue
  13.7.3 Brammer Bio Viral Vector Development Service Introduction
  13.7.4 Brammer Bio Revenue in Viral Vector Development Service Business (2015-2020)
  13.7.5 Brammer Bio Recent Development
13.8 Cell and Gene Therapy Catapult
  13.8.1 Cell and Gene Therapy Catapult Company Details
  13.8.2 Cell and Gene Therapy Catapult Business Overview and Its Total Revenue
  13.8.3 Cell and Gene Therapy Catapult Viral Vector Development Service Introduction
  13.8.4 Cell and Gene Therapy Catapult Revenue in Viral Vector Development Service Business (2015-2020)
  13.8.5 Cell and Gene Therapy Catapult Recent Development
13.9 Cobra Biologics
  13.9.1 Cobra Biologics Company Details
  13.9.2 Cobra Biologics Business Overview and Its Total Revenue
  13.9.3 Cobra Biologics Viral Vector Development Service Introduction
  13.9.4 Cobra Biologics Revenue in Viral Vector Development Service Business (2015-2020)
  13.9.5 Cobra Biologics Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Viral Vector Development Service Key Market Segments
Table 2. Key Players Covered: Ranking by Viral Vector Development Service Revenue
Table 3. Ranking of Global Top Viral Vector Development Service Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Viral Vector Development Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Retroviral Vectors
Table 6. Key Players of Lentiviral Vectors
Table 7. Key Players of Adenoviral Vectors
Table 8. Key Players of Adeno-associated Viral Vectors
Table 9. Key Players of Others Viral Vectors
Table 10. COVID-19 Impact Global Market: (Four Viral Vector Development Service Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Viral Vector Development Service Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Viral Vector Development Service Players to Combat Covid-19 Impact
Table 15. Global Viral Vector Development Service Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Viral Vector Development Service Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Viral Vector Development Service Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Viral Vector Development Service Market Share by Regions (2015-2020)
Table 19. Global Viral Vector Development Service Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Viral Vector Development Service Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Viral Vector Development Service Market Growth Strategy
Table 25. Main Points Interviewed from Key Viral Vector Development Service Players
Table 26. Global Viral Vector Development Service Revenue by Players (2015-2020) (Million US$)
Table 27. Global Viral Vector Development Service Market Share by Players (2015-2020)
Table 28. Global Top Viral Vector Development Service Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector Development Service as of 2019)
Table 29. Global Viral Vector Development Service by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Viral Vector Development Service Product Solution and Service
Table 32. Date of Enter into Viral Vector Development Service Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Viral Vector Development Service Market Size by Type (2015-2020) (Million US$)
Table 35. Global Viral Vector Development Service Market Size Share by Type (2015-2020)
Table 36. Global Viral Vector Development Service Revenue Market Share by Type (2021-2026)
Table 37. Global Viral Vector Development Service Market Size Share by Application (2015-2020)
Table 38. Global Viral Vector Development Service Market Size by Application (2015-2020) (Million US$)
Table 39. Global Viral Vector Development Service Market Size Share by Application (2021-2026)
Table 40. North America Key Players Viral Vector Development Service Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Viral Vector Development Service Market Share (2019-2020)
Table 42. North America Viral Vector Development Service Market Size by Type (2015-2020) (Million US$)
Table 43. North America Viral Vector Development Service Market Share by Type (2015-2020)
Table 44. North America Viral Vector Development Service Market Size by Application (2015-2020) (Million US$)
Table 45. North America Viral Vector Development Service Market Share by Application (2015-2020)
Table 46. Europe Key Players Viral Vector Development Service Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Viral Vector Development Service Market Share (2019-2020)
Table 48. Europe Viral Vector Development Service Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Viral Vector Development Service Market Share by Type (2015-2020)
Table 50. Europe Viral Vector Development Service Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Viral Vector Development Service Market Share by Application (2015-2020)
Table 52. China Key Players Viral Vector Development Service Revenue (2019-2020) (Million US$)
Table 53. China Key Players Viral Vector Development Service Market Share (2019-2020)
Table 54. China Viral Vector Development Service Market Size by Type (2015-2020) (Million US$)
Table 55. China Viral Vector Development Service Market Share by Type (2015-2020)
Table 56. China Viral Vector Development Service Market Size by Application (2015-2020) (Million US$)
Table 57. China Viral Vector Development Service Market Share by Application (2015-2020)
Table 58. Japan Key Players Viral Vector Development Service Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Viral Vector Development Service Market Share (2019-2020)
Table 60. Japan Viral Vector Development Service Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Viral Vector Development Service Market Share by Type (2015-2020)
Table 62. Japan Viral Vector Development Service Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Viral Vector Development Service Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Viral Vector Development Service Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Viral Vector Development Service Market Share (2019-2020)
Table 66. Southeast Asia Viral Vector Development Service Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Viral Vector Development Service Market Share by Type (2015-2020)
Table 68. Southeast Asia Viral Vector Development Service Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Viral Vector Development Service Market Share by Application (2015-2020)
Table 70. India Key Players Viral Vector Development Service Revenue (2019-2020) (Million US$)
Table 71. India Key Players Viral Vector Development Service Market Share (2019-2020)
Table 72. India Viral Vector Development Service Market Size by Type (2015-2020) (Million US$)
Table 73. India Viral Vector Development Service Market Share by Type (2015-2020)
Table 74. India Viral Vector Development Service Market Size by Application (2015-2020) (Million US$)
Table 75. India Viral Vector Development Service Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Viral Vector Development Service Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Viral Vector Development Service Market Share (2019-2020)
Table 78. Central & South America Viral Vector Development Service Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Viral Vector Development Service Market Share by Type (2015-2020)
Table 80. Central & South America Viral Vector Development Service Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Viral Vector Development Service Market Share by Application (2015-2020)
Table 82. UJIFILM Diosynth Biotechnologies Company Details
Table 83. UJIFILM Diosynth Biotechnologies Business Overview
Table 84. UJIFILM Diosynth Biotechnologies Product
Table 85. UJIFILM Diosynth Biotechnologies Revenue in Viral Vector Development Service Business (2015-2020) (Million US$)
Table 86. UJIFILM Diosynth Biotechnologies Recent Development
Table 87. Sanofi Company Details
Table 88. Sanofi Business Overview
Table 89. Sanofi Product
Table 90. Sanofi Revenue in Viral Vector Development Service Business (2015-2020) (Million US$)
Table 91. Sanofi Recent Development
Table 92. Spark Therapeutics Company Details
Table 93. Spark Therapeutics Business Overview
Table 94. Spark Therapeutics Product
Table 95. Spark Therapeutics Revenue in Viral Vector Development Service Business (2015-2020) (Million US$)
Table 96. Spark Therapeutics Recent Development
Table 97. UniQure Company Details
Table 98. UniQure Business Overview
Table 99. UniQure Product
Table 100. UniQure Revenue in Viral Vector Development Service Business (2015-2020) (Million US$)
Table 101. UniQure Recent Development
Table 102. MassBiologics Company Details
Table 103. MassBiologics Business Overview
Table 104. MassBiologics Product
Table 105. MassBiologics Revenue in Viral Vector Development Service Business (2015-2020) (Million US$)
Table 106. MassBiologics Recent Development
Table 107. FinVector Company Details
Table 108. FinVector Business Overview
Table 109. FinVector Product
Table 110. FinVector Revenue in Viral Vector Development Service Business (2015-2020) (Million US$)
Table 111. FinVector Recent Development
Table 112. Brammer Bio Company Details
Table 113. Brammer Bio Business Overview
Table 114. Brammer Bio Product
Table 115. Brammer Bio Revenue in Viral Vector Development Service Business (2015-2020) (Million US$)
Table 116. Brammer Bio Recent Development
Table 117. Cell and Gene Therapy Catapult Business Overview
Table 118. Cell and Gene Therapy Catapult Product
Table 119. Cell and Gene Therapy Catapult Company Details
Table 120. Cell and Gene Therapy Catapult Revenue in Viral Vector Development Service Business (2015-2020) (Million US$)
Table 121. Cell and Gene Therapy Catapult Recent Development
Table 122. Cobra Biologics Company Details
Table 123. Cobra Biologics Business Overview
Table 124. Cobra Biologics Product
Table 125. Cobra Biologics Revenue in Viral Vector Development Service Business (2015-2020) (Million US$)
Table 126. Cobra Biologics Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Viral Vector Development Service Market Share by Type: 2020 VS 2026
Figure 2. Retroviral Vectors Features
Figure 3. Lentiviral Vectors Features
Figure 4. Adenoviral Vectors Features
Figure 5. Adeno-associated Viral Vectors Features
Figure 6. Others Viral Vectors Features
Figure 7. Global Viral Vector Development Service Market Share by Application: 2020 VS 2026
Figure 8. Pharmaceutical Manufacturers Case Studies
Figure 9. Biotechnology Companies Case Studies
Figure 10. Research Institutes Case Studies
Figure 11. Viral Vector Development Service Report Years Considered
Figure 12. Global Viral Vector Development Service Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Viral Vector Development Service Market Share by Regions: 2020 VS 2026
Figure 14. Global Viral Vector Development Service Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Viral Vector Development Service Market Share by Players in 2019
Figure 17. Global Top Viral Vector Development Service Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viral Vector Development Service as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Viral Vector Development Service Revenue in 2019
Figure 19. North America Viral Vector Development Service Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Viral Vector Development Service Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Viral Vector Development Service Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Viral Vector Development Service Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Viral Vector Development Service Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Viral Vector Development Service Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Viral Vector Development Service Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. UJIFILM Diosynth Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. UJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Development Service Business (2015-2020)
Figure 28. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sanofi Revenue Growth Rate in Viral Vector Development Service Business (2015-2020)
Figure 30. Spark Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Spark Therapeutics Revenue Growth Rate in Viral Vector Development Service Business (2015-2020)
Figure 32. UniQure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. UniQure Revenue Growth Rate in Viral Vector Development Service Business (2015-2020)
Figure 34. MassBiologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. MassBiologics Revenue Growth Rate in Viral Vector Development Service Business (2015-2020)
Figure 36. FinVector Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. FinVector Revenue Growth Rate in Viral Vector Development Service Business (2015-2020)
Figure 38. Brammer Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Brammer Bio Revenue Growth Rate in Viral Vector Development Service Business (2015-2020)
Figure 40. Cell and Gene Therapy Catapult Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vector Development Service Business (2015-2020)
Figure 42. Cobra Biologics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Cobra Biologics Revenue Growth Rate in Viral Vector Development Service Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed